Search results for "BLOCKADE"

showing 10 items of 164 documents

Effect of chronic exercise and ATP-sensitive potassium channel blockade on the spectral characteristics evolution of ventricular fibrillation in acut…

2013

Purpose: It has been proposed that chronic exercise produces a KATP channel blockade in ischemic myocardium. We have also reported that channel blockade and training exert very similar effects on energy required to defibrillate. In fact it is postulated that one mechanism by which exercise exerts an antiarrhythmic effect, is by blocking KATP channel. We have analyzed the evolution of spectrum characteristics of ventricular fibrillation (VF), in normoxic conditions and after acute myocardial ischemia, in isolated hearts from trained rabbits, and in hearts submitted to KATP channel blockade. Our hypothesis is that the spectrum characteristics of VF evolve similarly in trained hearts and in he…

medicine.medical_specialtyATP-sensitive potassium channelbusiness.industryIschemiamedicine.diseaseBlockadeGlibenclamidemedicine.anatomical_structureVentricleCoronary occlusionAnesthesiaInternal medicineVentricular fibrillationCardiologymedicineCardiology and Cardiovascular MedicinebusinessAnti-Arrhythmia Agentsmedicine.drugEuropean Heart Journal
researchProduct

Experiences with Blockade of the Renin System in Human Hypertension Using Converting Enzyme Inhibitor SQ 20,881 and Saralasin

1980

The development of agents which are capable of producing in vivo angiotensin II blockade has provided to investigators and clinicians alike the opportunity to determine and to quantify the extent to which the renin-angiotensin system participates in the maintenance of hypertensive states. High levels of plasma renin activity relative to the state of sodium balance have been documented in patients with malignant, surgically remediable renovascular hypertension and also in some patients with essential hypertension.1 The recent development of the angiotensin II analogue sar1-ala8-angiotensin II (saralasin) provided evidence to support the concept that these elevated renin levels are in fact pa…

medicine.medical_specialtyAngiotensin II receptor type 1business.industryPharmacologymedicine.diseaseAngiotensin IIPlasma renin activityBlockadeRenovascular hypertensionchemistry.chemical_compoundEndocrinologychemistryPathophysiology of hypertensionInternal medicineRenin–angiotensin systemMedicinebusinessSaralasin
researchProduct

Behandlung der ausgeprägten Pubertätsgynäkomastie mit Tamoxifen

1987

Based on the good results of another author 10 boys with marked pubertal gynecomastia were treated with the antioestrogen Tamoxifen (Nolvadex) at a dose of 20-40 mg/d orally for 2-12 months. In most cases the gynecomastia decreased totally, only two patients experienced palpable subareolar glandular tissue at the end of therapy. Side effects were not noted. During therapy levels of estradiol and testosteron increased, with a more pronounced elevation of estradiol. Basal values of LH and FSH remained nearly unchanged, but LH showed an increased response to LH-RH, which could be explained by the antioestrogenic effect of Tamoxifen at the hypothalamic level. The reduction of breast size in spi…

medicine.medical_specialtyChemotherapyEnd of therapybusiness.industrymedicine.medical_treatmentTherapeutic effectEstrogen receptormedicine.diseaseBlockadeBasal (phylogenetics)EndocrinologyGynecomastiaInternal medicinePediatrics Perinatology and Child Healthmedicineskin and connective tissue diseasesbusinesshormones hormone substitutes and hormone antagonistsTamoxifenmedicine.drugKlinische Pädiatrie
researchProduct

Vascular Dysfunction and Oxidative Stress in Diabetic Rats - Comparison of Beneficial Effects of AT1- Receptor Blockade, Calcium Antagonist, or Combi…

2013

medicine.medical_specialtyCombination therapybusiness.industryAntagonistchemistry.chemical_elementPharmacologyCalciummedicine.disease_causeBiochemistryEndocrinologyAt1 receptor blockadechemistryPhysiology (medical)Internal medicinemedicinebusinessBeneficial effectsOxidative stressFree Radical Biology and Medicine
researchProduct

TNF-α blockade may lead to improvement of vascular function in psoriasis patients.

2021

Psoriasis is one of the most common chronic inflammatory skin diseases and at the same time a risk factor for cardiovascular disease. Interleukin-17A (IL-17A)-mediated inflammation in psoriasis may lead to vascular dysfunction. This study aimed at investigating whether anti-inflammatory treatment by tumor necrosis factor (TNF)-α blockade alters vascular function in psoriasis patients. A total of 11 patients with psoriasis who underwent treatment with either adalimumab (n = 8) or etanercept (n = 3), 10 healthy control individuals and 14 patients with coronary artery disease (CAD) were included in this study. Treatment response was assessed using the Psoriasis Area and Severity Index (PASI) s…

medicine.medical_specialtyDermatologyBiochemistryGastroenterologyEtanerceptCoronary artery diseasePsoriasis Area and Severity IndexInternal medicinePsoriasismedicineAdalimumabHumansPsoriasisRisk factorMolecular Biologybusiness.industryTumor Necrosis Factor-alphamedicine.diseaseBlockadeVasodilationVasoconstrictionChronic DiseaseTumor necrosis factor alphaTumor Necrosis Factor InhibitorsEndothelium Vascularbusinessmedicine.drugExperimental dermatologyREFERENCES
researchProduct

Role of antiangiogenic VEGF-A165b in angiogenesis and systolic function after reperfused myocardial infarction

2021

Abstract Introduction and objectives Angiogenesis helps to reestablish microcirculation after myocardial infarction (MI). In this study, we aimed to further understand the role of the antiangiogenic isoform vascular endothelial growth factor (VEGF)-A165b after MI and to explore its potential as a coadjuvant therapy to coronary reperfusion. Methods Two mice MI models were formed: a) permanent coronary ligation (nonreperfused MI); b) transient 45-minute coronary occlusion followed by reperfusion (reperfused MI); in both models, animals underwent echocardiography before euthanasia at day 21 after MI induction. We determined serum and myocardial VEGF-A165b levels. In both experimental MI models…

medicine.medical_specialtyEjection fractionbusiness.industryAngiogenesisGeneral Medicine030204 cardiovascular system & hematologymedicine.diseaseMicrocirculationBlockadeVascular endothelial growth factor03 medical and health scienceschemistry.chemical_compound0302 clinical medicinechemistryCoronary occlusionHeart failureInternal medicinemedicineCardiologyMyocardial infarctionbusinessRevista Española de Cardiología (English Edition)
researchProduct

Gastrin: an acid-releasing, proliferative and immunomodulatory peptide?

2010

Gastrin release is affected by gastric inflammatory conditions. Antral G cells respond to inflammatory mediators by increasing gastrin secretion. Accumulating experimental evidence suggests that gastrin exerts immunomodulatory and proinflammatory effects. Gastrin could be a contributing factor to these pathologies, which may constitute a new justification for pharmacological blockade of gastrin action.

medicine.medical_specialtyInflammationdigestive systemProinflammatory cytokineGastric AcidImmunomodulationInternal medicineDrug DiscoveryGastrinsmedicineAnimalsHumansSecretionGastrin-Secreting CellsProtein PrecursorsAntrumGastrinCell ProliferationPharmacologyChemistrydigestive oral and skin physiologyGeneral MedicineBlockadeImmunomodulatory peptideEndocrinologyGastrinomaGastritisReceptors CholecystokininG cellmedicine.symptomhormones hormone substitutes and hormone antagonistsSignal TransductionMini reviews in medicinal chemistry
researchProduct

Intraoperative Überwachung der Relaxierung

2000

medicine.medical_specialtyNeuromuscular BlockadeAnesthesiology and Pain MedicineMuscle relaxationRelaxation (psychology)business.industryAnesthesiologyAnesthesiaPain medicinemedicineGeneral MedicinebusinessElectric stimulationDer Anaesthesist
researchProduct

A 35-year effective treatment of catecholaminergic polymorphic ventricular tachycardia with propafenone

2018

Key Teaching Points • Despite proven catecholaminergic polymorphic ventricular tachycardia (CPVT) with pathogen RyR2 mutation and recurrent syncope, patients could have a favorable long-term outcome over 35 years under treatment. • Propafenone could be effective for treatment of patients with CPVT. • The beneficial effect of the monotherapy with propafenone in our patient may result from the combined antiarrhythmic effect of this drug with Na+ channel blockade and beta blocker capabilities.

medicine.medical_specialtyPolymorphic premature ventricular beatsmedicine.drug_classCase ReportPropafenone030204 cardiovascular system & hematologyCatecholaminergic polymorphic ventricular tachycardiaRyanodine receptor 203 medical and health sciences0302 clinical medicinePropafenoneInternal medicineMedicineEffective treatment030212 general & internal medicineExercise-induced syncopeBeta blockerbusiness.industrymedicine.diseaseBlockadeExercise-induced syncopeCatecholaminergic polymorphic ventricular tachycardiacardiovascular systemCardiologyAntiarrhythmic effectCardiology and Cardiovascular MedicinebusinessRyanodine receptor mutationmedicine.drugHeartRhythm Case Reports
researchProduct

Studies using pharmacological blockade of muscle afferents provide new insights into the neurophysiology of perceived exertion

2016

The increase in blood pressure observed during physical activities is exaggerated in patients with hypertension, exposing them to a higher cardiovascular risk.Neural signals from the skeletal muscles appear to be overactive, resulting in this abnormal response in hypertensive patients.In the present study, we tested whether the attenuation of these neural signals in hypertensive patients could normalize their abnormal increase in blood pressure during physical activity.Attenuation of the neural signals from the leg muscles with intrathecal fentanyl injection reduced the blood pressure of hypertensive men during cycling exercise to a level comparable to that of normotensive men.Skeletal musc…

medicine.medical_specialty[SDV.MHEP.PHY] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]PhysiologyPhysical ExertionPerceived exertionCardiovascular03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitation[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system[SDV.MHEP.PHY]Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]medicineHumans[SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]Muscle SkeletalComputingMilieux_MISCELLANEOUS[ SDV.MHEP.PHY ] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]Muscles030229 sport sciences[ SDV.MHEP.CSC ] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemNeurophysiology[SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemBlockade[ SDV.NEU ] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC][SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]PsychologyNeuroscience030217 neurology & neurosurgeryMuscle ContractionThe Journal of Physiology
researchProduct